Glutamate receptor antagonists attenuate experimental catalepsy in rats
Rukoiatkina, N.I.; Gorbunova, L.V.; Gmiro, V.E.; Lukomskaia, N.I.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 86(6): 626-633
2000
ISSN/ISBN: 0869-8139 PMID: 10955300 Document Number: 514168
A long-term akinesia induced by haloperidol used as an experimental model of catalepsy helped to reveal that a dicationic derivatives adamantane (IEM-1754) and phenylcyclohexyl (IEM-1925) exerted different degrees of inhibition of the haloperidol effect: the IEM-1754 proved to be not inferior to the most effective NMDA antagonist MK-801. A relatively low potency of the IEM-1925 may be due to its obvious equal effects both on the NMDA and the AMPA receptor channels. A good correlation between the anticataleptic effects of the glutamate antagonists and the NMDA receptor blocking activity, were found. The AMPA receptor blockade might negatively affect the anticataleptic potency of the drugs under study.